Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Riess

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Cardiothoracic and Vascular Anesthesia|June 1, 1997
Recombinant hirudin is a heparin alternative in cardiac surgeryF C Riess, N Bleese, J Kormann, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1995
Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in manF C Riess, C Löwer, C Seelig, et al.
Anesthesiology|February 15, 2001
Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermiaF C Riess, M Fiege, S Moshar, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1996
A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgeryF C Riess, B Pötzsch, R Bader, et al.
The Annals of Thoracic Surgery|October 13, 1998
Beating heart operations including hybrid revascularization: initial experiencesF C Riess, J Schofer, P Kremer, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 1, 1997
Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig modelF C Riess, B Pötzsch, I Behr, et al.
The Thoracic and Cardiovascular Surgeon|June 5, 2007
Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot studyF-C Riess, B Poetzsch, K Madlener, et al.
The Thoracic and Cardiovascular Surgeon|March 28, 2008
Preexisting atrial fibrillation as predictor for late-time mortality in patients with end-stage renal disease undergoing cardiac surgery--a multicenter studyM Schönburg, T Ziegelhoeffer, F Weinbrenner, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Cardiothoracic and Vascular Anesthesia|June 1, 1997
Recombinant hirudin is a heparin alternative in cardiac surgeryF C Riess, N Bleese, J Kormann, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1995
Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in manF C Riess, C Löwer, C Seelig, et al.
Anesthesiology|February 15, 2001
Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermiaF C Riess, M Fiege, S Moshar, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1996
A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgeryF C Riess, B Pötzsch, R Bader, et al.
The Annals of Thoracic Surgery|October 13, 1998
Beating heart operations including hybrid revascularization: initial experiencesF C Riess, J Schofer, P Kremer, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 1, 1997
Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig modelF C Riess, B Pötzsch, I Behr, et al.
The Thoracic and Cardiovascular Surgeon|June 5, 2007
Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot studyF-C Riess, B Poetzsch, K Madlener, et al.
The Thoracic and Cardiovascular Surgeon|March 28, 2008
Preexisting atrial fibrillation as predictor for late-time mortality in patients with end-stage renal disease undergoing cardiac surgery--a multicenter studyM Schönburg, T Ziegelhoeffer, F Weinbrenner, et al.
Pageof 2